Case Report: A rare case of gastric cardia bronchogenic cyst: diagnostic challenges and EUS findings with elevated cyst-fluid tumor markers - Scorecard - MDSpire
Advertisement
Case Report: A rare case of gastric cardia bronchogenic cyst: diagnostic challenges and EUS findings with elevated cyst-fluid tumor markers
Clinical Scorecard: Uncommon Presentation of a Bronchogenic Cyst in the Gastric Cardia: Diagnostic Difficulties and EUS Findings with Elevated Tumor Markers in Cyst Fluid
At a Glance
Category
Detail
Condition
Bronchogenic Cyst
Key Mechanisms
Congenital foregut malformation, cystic lesion in gastric cardia
Target Population
Adults, specifically a case of a 36-year-old male
Care Setting
Gastroenterology and surgical intervention
Key Highlights
Bronchogenic cysts are rare, with gastric cardia involvement being exceptionally uncommon.
Endoscopic ultrasound (EUS) is crucial for localizing and characterizing subepithelial cystic lesions.
Cyst-fluid analysis revealed elevated tumor markers but should not be interpreted as malignancy in isolation.
Laparoscopic cyst excision was performed due to diagnostic uncertainty and symptomatic presentation.
Histopathological examination confirmed the diagnosis of a bronchogenic cyst.
Guideline-Based Recommendations
Diagnosis
Utilize imaging techniques such as CT and MRI to assess cystic lesions.
Endoscopic ultrasound (EUS) is recommended for detailed characterization.
Management
Laparoscopic resection is indicated for symptomatic lesions with uncertain diagnosis.
Monitoring & Follow-up
Follow-up is necessary to check for recurrence post-surgery.
Risks
Elevated tumor markers in cyst fluid may lead to misinterpretation as malignancy.
Patient & Prescribing Data
Adult males with abdominal symptoms and cystic lesions in the gastric cardia.
Surgical intervention is warranted in cases of diagnostic uncertainty and significant symptoms.
Clinical Best Practices
Consider differential diagnoses including GIST and other cystic lesions.
Interpret cyst-fluid tumor markers cautiously, as they may not indicate malignancy.
For hepatologists and other physicians who treat patients with advanced liver disease, the gap between the number of patients who need transplant and the number of available organs is a familiar challenge.